📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhaled corticosteroid suppression of cathelicidin drives dysbiosis and bacterial infection in chronic obstructive pulmonary disease. (2019)

First Author: Singanayagam A

Attributed to: MRC Centre for Molecular Bacteriology and Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aav3879

PubMed Identifier: 31462509

Publication URI: http://europepmc.org/abstract/MED/31462509

Type: Journal Article/Review

Volume: 11

Parent Publication: Science translational medicine

Issue: 507

ISSN: 1946-6234